Form D · Pharmaceuticals
Tioga Pharmaceuticals Inc
San Diego, CA · CIK 0001331886
Offering snapshot reported Apr 10, 2012 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2012 | Initial | $10,000,000 | No comparison | 4 | SEC filing |
| Feb 22, 2010 | Initial | $9,263,273 | No comparison | 4 | SEC filing |
| Oct 26, 2009 | Initial | $3,000,000 | No comparison | 3 | SEC filing |
| May 27, 2009 | Initial | $2,000,000 | No comparison | Not reported | SEC filing |
| Jun 27, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-176402
Source: Form D, filed Apr 10, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Brown | Director |
| Stuart J.M. Collinson | Director, Executive |
| Arno Hartmann | Director |
| Gareth Hicks | Executive |
| Allen Mangel | Executive |
| Martin Meunchbach | Director |
| Martin Muenchbach | Director |
| James Niedel | Director |
| David M. Urso | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9393 Towne Centre Dr Suite 200
San Diego, CA, 92121
San Diego, CA, 92121